Abstract | OBJECTIVE: To discuss the regulating mechanism of iron regulatory protein-2 (IRP2) in the iron metabolism of lung cancer. METHODS: RESULTS: After a 48-hour transfection, the mRNA expression of Tf had no statistically significant difference among three groups (F = 2.18, P = 0.078); the mRNA expression of TfR in the ASODN group was significantly lower than that in the liposome and SCODN groups (P < 0.05). The expression of Fn mRNA in the ASODN group (0.56 ± 0.06) was higher than that in the liposome (0.36 ± 0.05) and SCODN groups (0.39 ± 0.03) (P < 0.05). After a 48-hour transfection, the IRP2 protein expression of the ASODN group was significantly lower than those of the liposome and SCODN groups (P < 0.05). The Tf protein expression was not statistically different in three groups (F = 2.67, P = 0.088). The TfR protein expression of the ASODN group was lower than those of the liposome and SCODN groups (P < 0.05). And the Fn protein expression of the ASODN group was higher than those of the liposome and SCODN groups (P < 0.05). CONCLUSION:
|
Authors | Zhe Cheng, Yu-feng Liu, Yong-na Song, Ling-ling Dai, Yan Kang, Jie Xia, Ji-ming Si, Chun-yan Chen |
Journal | Zhonghua yi xue za zhi
(Zhonghua Yi Xue Za Zhi)
Vol. 91
Issue 28
Pg. 1992-5
(Jul 26 2011)
ISSN: 0376-2491 [Print] China |
PMID | 22093897
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Liposomes
- Oligodeoxyribonucleotides, Antisense
- Receptors, Transferrin
- Ferritins
- Iron
- IREB2 protein, human
- Iron Regulatory Protein 2
|
Topics |
- Adenocarcinoma
(metabolism)
- Adenocarcinoma of Lung
- Cell Line, Tumor
- Ferritins
(metabolism)
- Humans
- Iron
(metabolism)
- Iron Regulatory Protein 2
(genetics, metabolism)
- Liposomes
(administration & dosage)
- Lung Neoplasms
(metabolism)
- Oligodeoxyribonucleotides, Antisense
(genetics)
- Receptors, Transferrin
(metabolism)
|